|
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 235.53 USD | -1.51% |
|
-0.47% | +48.79% |
| 05.12. | Natera schließt Uuml;bernahme von Foresight Diagnostics in reiner Aktien-Transaktion ab | MT |
| 05.12. | Natera übernimmt Foresight Diagnostics | RE |
Hauptkonkurrenten
| Umsatz (N-1) | Nettogewinn (N-1) | EBIT-Marge (N-1) | ROE (N-1) | ROA (N-1) | Verschuldungsgrad (N-1) | ||
|---|---|---|---|---|---|---|---|
| 1.7 Mrd. | -11.22% | -13.1% | -19.42% | -13.87% | 4.64x | ||
| 6.32 Mrd. | 5.32% | 9.43% | 6.32% | 3.33% | 1.63x | ||
| 1.83 Mrd. | 0.15% | 5.72% | 0.29% | 0.09% | 0.99x | ||
| 305 Mio. | -17.12% | 3.15% | - | - | -3.46x | ||
| 288 Mio. | 19.79% | 22.49% | 24.22% | 18.83% | -1.45x | ||
| 985 Mio. | -5.3% | -3.8% | -4.9% | -3.44% | -1.84x | ||
| 661 Mio. | -11.92% | -13.94% | 1.55% | - | 6.02x | ||
| 1.24 Mrd. | 8.02% | 15.59% | 11.88% | 5% | 1.54x | ||
| 1.67 Mrd. | -2.93% | -0.26% | -5% | 1.64% | 1x | ||
| 1.62 Mrd. | 1.14% | 1.09% | 2% | 1.66% | 1.56x | ||
| 79.74 Mio. | 21% | 29.74% | 19.7% | - | -0.85x | ||
| 156 Mio. | 10.89% | 14.6% | 11.95% | - | -0.11x | ||
| 713 Mio. | -7.46% | -21.33% | - | - | - | ||
| 956 Mio. | 4.37% | 6.54% | 4.9% | 5.72% | - | ||
| 283 Mio. | -15.07% | -26.08% | 1.32% | - | 90.87x | ||
| 289 Mio. | 9.21% | 10.97% | 7.93% | 5.44% | - | ||
| 80.44 Mio. | - | - | - | - | - | ||
| 411 Mio. | 0.77% | 11.16% | 6.35% | 2.91% | 2.29x | ||
| 104 Mio. | -6.04% | -3.56% | -3.34% | - | - | ||
| Durchschnitt | 1.04 Mrd. | 0.2% | 2.69% | 4.11% | 2.48% | 7.34x | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | 1.86 Mrd. | -5.11% | -3.37% | -7.5% | -6.34% | 3.71x |
- Börse
- Aktien
- A14VPJ Aktie
- Sektor Natera, Inc.
- Finanzielle Vergleiche
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben
















